Catalent Inc (CTLT)
56.50
+0.16
(+0.28%)
USD |
NYSE |
May 03, 16:00
56.50
0.00 (0.00%)
After-Hours: 20:00
Catalent Price to Book Value: 2.770 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 2.770 |
| May 02, 2024 | 2.762 |
| May 01, 2024 | 2.745 |
| April 30, 2024 | 2.738 |
| April 29, 2024 | 2.760 |
| April 26, 2024 | 2.741 |
| April 25, 2024 | 2.735 |
| April 24, 2024 | 2.743 |
| April 23, 2024 | 2.747 |
| April 22, 2024 | 2.748 |
| April 19, 2024 | 2.720 |
| April 18, 2024 | 2.735 |
| April 17, 2024 | 2.743 |
| April 16, 2024 | 2.734 |
| April 15, 2024 | 2.749 |
| April 12, 2024 | 2.760 |
| April 11, 2024 | 2.790 |
| April 10, 2024 | 2.795 |
| April 09, 2024 | 2.795 |
| April 08, 2024 | 2.779 |
| April 05, 2024 | 2.782 |
| April 04, 2024 | 2.792 |
| April 03, 2024 | 2.778 |
| April 02, 2024 | 2.767 |
| April 01, 2024 | 2.764 |
| Date | Value |
|---|---|
| March 28, 2024 | 2.767 |
| March 27, 2024 | 2.769 |
| March 26, 2024 | 2.758 |
| March 25, 2024 | 2.765 |
| March 22, 2024 | 2.735 |
| March 21, 2024 | 2.738 |
| March 20, 2024 | 2.739 |
| March 19, 2024 | 2.743 |
| March 18, 2024 | 2.743 |
| March 15, 2024 | 2.756 |
| March 14, 2024 | 2.779 |
| March 13, 2024 | 2.774 |
| March 12, 2024 | 2.770 |
| March 11, 2024 | 2.785 |
| March 08, 2024 | 2.770 |
| March 07, 2024 | 2.763 |
| March 06, 2024 | 2.777 |
| March 05, 2024 | 2.792 |
| March 04, 2024 | 2.792 |
| March 01, 2024 | 2.804 |
| February 29, 2024 | 2.811 |
| February 28, 2024 | 2.840 |
| February 27, 2024 | 2.853 |
| February 26, 2024 | 2.857 |
| February 23, 2024 | 2.881 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.219
Minimum
May 16 2023
6.212
Maximum
Sep 08 2021
3.909
Average
4.288
Median
Jun 08 2022
Price to Book Value Benchmarks
| Eli Lilly and Co | 54.52 |
| Merck & Co Inc | 8.594 |
| Elanco Animal Health Inc | 1.074 |
| Amgen Inc | 33.25 |
| Avrobio Inc | 0.5779 |
Price to Book Value Related Metrics
| PS Ratio | 2.509 |
| Price | 56.50 |
| Earnings Yield | -12.50% |
| Market Cap | 10.21B |